DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

Electronic Prescribing Requirements
October 21, 2019

Click here for the new requirements requiring prescribers to generate and transmit all prescriptions electronically Continue reading


Scam Calls
September 25, 2019

Click here for more information regarding scam calls for license holders claiming to be with the Florida Board. Continue reading




Supporting Documents
Medical Degree Verification
NICA FORM
Postgraduate Training Verification